THIRD QUARTER INTERIM REPORT PRESENTATION 9 NOVEMBER 2017
|
|
- Caroline O’Neal’
- 5 years ago
- Views:
Transcription
1 THIRD QUARTER INTERIM REPORT PRESENTATION 9 NOVEMBER 2017
2 THOMAS ELDERED CEO
3 THIRD QUARTER 2017 Continued focused strategy implementation Sales adjusted for Fx and acquisitions -0.8% YoY 16% Sales, YoY growth Adjusted for Fx and acquisitions 16% EBITDA margin 8.6% (12.6) 6% 6% 5% Third quarter holiday and maintenance shutdowns Delays in Wasserburg, Bengaluru and the US Impact from ongoing expansion projects Swedish operations underperforming Operating cash flow at 149 MSEK Balancing capex Events after closing -3% -1% Q Q2 Q3 Q4 Q Q2 Q3 139 Operating cash flow (MSEK) Intention to end operations in Stockholm and Höganäs Q Q2 Q3 Q4 Q Q2 Q3 3
4 STRATEGY EXECUTION PROGRESS Several potential portfolio outsourcing projects agreement with Roche Increased number of development projects, building an encouraging pipeline of products new to the market. Launched Recipharm Pathway to Clinic Focused efforts in own products and technologies, support to erdosteine Implementation of contracts and new contract wins in Bengaluru Strong development in underlying manufacturing business with a large number of tech transfers ongoing, including customers for expanded capacity in Sterile Liquids segment Continued review of less profitable customer contracts Streamlining of operations and exploring opportunities with our global structure intention to end operations in Stockholm and Höganäs communicated after the period end 4
5 ONGOING SIGNIFICANT CAPEX PROJECTS UPDATE Lyophilisation and packaging capacity expansion in Wasserburg, Germany Staff training and test runs ongoing Capex will be finished in Q4-17, material start-up opex Ramp-up of commercial supply expected to begin end of Q1-18 Blow-fill-seal capacity expansion in Kaysersberg, France Test runs to start during Q4-17 Capex will finish Q1-18, revamping in Q3-17 impacting sales and profit Ramp-up of commercial supply expected during Q2-18 Lyophilisation capacity expansion in Masate, Italy Capex on-going, expected finish Q3-18 Commercial supply expected during Q4-18 Serialisation technology, globally Implementation on-going, according to plan Main impact expected from Q2-19 5
6 EVENT AFTER THE PERIOD INTENTION TO END OPERATIONS IN STOCKHOLM AND HÖGANÄS Will address underperformance in Swedish operations Current EBITDA run rate 25 SEK million p.a. Expanded network in Solids and Others offers opportunities to optimize and streamline Will affect approximately 225 employees, negotiations with unions will start today Contracts will be terminated, customers offered continued supply from other parts of Recipharm s manufacturing network Non-recurring costs expected to be charged Q4-17 Operations expected to end 2018 (Höganäs) and 2019 (Stockholm) An important step in overall streamlining operations strategy Will improve competitiveness, efficiency and improve market position 6
7 HENRIK STENQVIST CFO (currency SEK million)
8 Q3 P&L DEVELOPMENT Q Q Net Sales EBITDA EBITDA margin 8,6 12,6 D&A EBIT Financial Items Profit before Tax Tax 9-10 Net Profit
9 MANUFACTURING SERVICES STERILE LIQUIDS SALES BRIDGE, JULY SEPTEMBER Sales, MSEK Sales, % Currency Acquisitions Organic growth Total Q Currency Organic growth Q EBITDA BRIDGE, JULY SEPTEMBER SEK million EBITDA Currency -0.7 Acquisitions 0.0 Other Total Q Currency Other Q
10 MANUFACTURING SERVICES SOLIDS & OTHERS SALES BRIDGE, JULY SEPTEMBER Sales, MSEK Sales, % Currency Acquisitions Organic Total EBITDA BRIDGE, JULY SEPTEMBER SEK million EBITDA Currency -0.1 Acquisitions 2.9 Other Total Q Currency Acquisitions Organic growth Q Q Currency Acquisitions Other Q
11 DEVELOPMENT & TECHNOLOGY SALES BRIDGE, JULY SEPTEMBER Sales, MSEK Sales, % Currency Acquisitions Organic Total EBITDA BRIDGE, JULY SEPTEMBER Q Currency Acquisitions Organic growth Q SEK million EBITDA Currency 0.4 Acquisitions 1.0 Other 10.4 Total Q Currency Acquisitions Organic growth Q
12 EBITDA BRIDGE VS Q ,0 160,0 Capacity Expansion sites 140,0 120,0 Q Swedish Operations Development & Technology Other 100,0 80,0 Q ,0 40,0 20,0 0,0 12
13 CASH FLOW BY QUARTER msek Q1 Q2 Q3 YTD Operating Cash Flow Changes in Working capital Operating cash flow after w.c Maintenance capex Free cash flow Expansion capex Cash flow after investing activities
14 THOMAS ELDERED CEO
15 EXECUTING ON OUR FOCUSED STRATEGY Q3: Not where we should be, and not where we will be Contributions to growth and profitability Commercial supply from all three major expansion projects Manufacturing network optimization and streamlining Important contract wins, with Roche as the largest Gradual catch-up in Bengaluru, India Optimised development offering On track to reach our financial targets Sales target of at least SEK 8 bn by 2020 At least 16% EBITDA margin 15
16 Q&A
17 CONTACT INFORMATION Thomas Eldered CEO & Managing Director +46 (0) Henrik Stenqvist CFO & EVP +46 (0) , 17
FOURTH QUARTER REPORT PRESENTATION THOMAS ELDERED CEO
FOURTH QUARTER REPORT PRESENTATION THOMAS ELDERED CEO FOURTH QUARTER 2017 Positive ending of an eventful year Good recovery in current business Strong performance in D&T All the major projects now on track
More informationQ1 PRESENTATION 27 APRIL 2017
Q1 PRESENTATION 27 APRIL 2017 1 RECORD SALES BUT WEAK EBITDA Net sales SEKm 1 328, up 37% EBITDA SEKm 159, up 17% EBITDA margin 12% vs 14% Profit after tax SEKm 1 (25) Operating CF SEKm -25 (-60) Net debt/equity
More informationQ2 PRESENTATION. 25 July 2017
Q2 PRESENTATION 25 July 2017 RECORD SALES AND EBITDA Net sales 1,401 up 13% Profit after tax 76 (84) EBITDA 242 up 1% Operating CF 154 (139) EBITDA margin 17% vs 19% Net debt/equity 0.6 (0.4) NET SALES
More informationINTERIM REPORT JANUARY DECEMBER 2017
INTERIM REPORT JANUARY DECEMBER 2017 INTERIM REPORT OCTOBER DECEMBER 2017 Net sales amounted to SEK 1,403 million (1,333), an increase of 5.3% EBITDA amounted to SEK 226 million (229) corresponding to
More informationINTERIM REPORT JANUARY SEPTEMBER 2017
INTERIM REPORT JANUARY SEPTEMBER 2017 INTERIM REPORT JULY SEPTEMBER 2017 Net sales amounted to SEK 1,200 million (1,138), an increase of 5.5% amounted to SEK 103 million (144) corresponding to an margin
More informationQ PRESENTATION 24 FEBRUARY 2016
Q4 2015 PRESENTATION 24 FEBRUARY 2016 1 HIGHLIGHTS THOMAS ELDERED, CEO 2 HIGHLIGHTS Q4 Net sales SEK 863 million, decrease of 1.1% EBITDA SEK 110 million, decrease of 25% EBITDA-margin 12.7%, decrease
More informationINTERIM REPORT JANUARY JUNE 2017
INTERIM REPORT JANUARY JUNE 2017 INTERIM REPORT APRIL JUNE 2017 Net sales amounted to SEK 1,401 million (1,235), an increase of 13.4% increased by 0.9% and amounted to SEK 242 million (240) corresponding
More informationQ PRESENTATION 23 JULY 2015
Q2 2015 PRESENTATION 23 JULY 2015 1 HIGHLIGHTS THOMAS ELDERED, CEO 2 HIGHLIGHTS Q2 Another quarter with solid progress +42% Net Sales growth (+40% LC) +58% EBITDA growth EBITDA-margin firmly established
More informationINTERIM REPORT JANUARY SEPTEMBER 2018
INTERIM REPORT JANUARY SEPTEMBER 2018 INTERIM REPORT JULY SEPTEMBER 2018 Net sales amounted to SEK 1,421 million (1,200), an increase of 18% EBITDA increased by 47% and amounted to SEK 151 million (103)
More informationRecipharm to acquire Corvette Pharmaceutical Services Group
Recipharm to acquire Corvette Pharmaceutical Services Group 19 th August 2014 Thomas Eldered, CEO Björn Westberg, CFO Recipharm is stepping up Increased reach, capacity, capability, scale and profitability
More informationInterim report JANUARY DECEMBER February 2017
Interim report JANUARY DECEMBER 2016 23 February 2017 October - December 2016 Net sales amounted to SEK 1 333 million (863), an increase of 54% EBITDA increased by 108% and amounted to SEK 229 million
More informationGLOBAL FOOTPRINT CREATES VALUE ANNUAL REPORT 2016
GLOBAL FOOTPRINT CREATES VALUE ANNUAL REPORT 2016 CONTENT Introduction Recipharm in brief 1 Year in brief 2 CEO statement 4 Market Our market 6 Our customers 10 Strategy and targets Our targets 11 Strategy
More informationInterim report JANUARY JUNE July 2016
Interim report JANUARY JUNE 2016 22 July 2016 0BApril - June 2016 Net sales amounted to SEK 1 235 million (868), an increase of 42 % EBITDA increased by 54 % and amounted to SEK 240 million (156) giving
More informationMr Green & Co AB. Interim Report January-June Per Norman CEO & Simon Falk CFO. 21 July 2017 conference call
Mr Green & Co AB Interim Report January-June 2017 Per Norman CEO & Simon Falk CFO 21 July 2017 conference call Revenues +36.3% EBITDA margin 18.2% Customer deposits +34.4% Q217 vs Q216 2 Strong financial
More informationRecipharm to acquire majority stake in Indian CMO Nitin Lifesciences creating Emerging Markets platform
Press release 20 October 2015 Recipharm to acquire majority stake in Indian CMO Nitin Lifesciences creating Emerging Markets platform The contract development and manufacturing organisation, Recipharm
More informationFULL YEAR REPORT, 2017 TELEPHONE/AUDIO CONFERENCE 8 FEBRUARY 2018, AT CET TOMMY ANDERSSON, PRESIDENT AND CEO HELENA WENNERSTRÖM, EVP AND CFO
TELEPHONE/AUDIO CONFERENCE 8 FEBRUARY 2018, AT 15.30 CET TOMMY ANDERSSON, PRESIDENT AND CEO HELENA WENNERSTRÖM, EVP AND CFO DIRECT LINK AUDIOCAST: HTTPS://TV.STREAMFABRIKEN.COM/BULTEN Q4 2017 TELECONFERENCE:
More informationUDG Healthcare plc Interim Results Presentation FY17. London Stock Exchange, 23 rd May 2017
UDG Healthcare plc Interim Results Presentation FY17 London Stock Exchange, 23 rd May 2017 Forward looking statements This Presentation has been prepared by UDG Healthcare plc and contains certain forward-looking
More informationINTERIM REPORT JULY 17 SECOND QUARTER 2014
INTERIM REPORT JULY 17 SECOND QUARTER 2014 SUMMARY Q2 2014 DELIVERY ON OUR STRATEGIC AGENDA Closure of 4 additional production units initiated Varel acquisition finalized STABLE MARKET CONDITIONS Overall
More informationTradedoubler. Interim report January-March 2014 May 6, 2014
Tradedoubler Interim report January-March 2014 May 6, 2014 1 Agenda Introduction of new acting CEO Q1 in brief Q1 Financials Going Forward Q&A Tradedoubler in brief 2 Matthias Stadelmeyer Acting CEO since
More informationInvestor presentation. November, 2018
Investor presentation November, 2018 This is NetEnt Develops games and solutions for the online casino market Listed on Stockholm Stock Exchange TABLE GAMES 8% 200 active customers 20 regulated markets
More informationFredrik Nilsson Chief Financial Officer and acting Chief Executive Officer. CFO update. The Co-Development Company
Fredrik Nilsson Chief Financial Officer and acting Chief Executive Officer CFO update How we measure success Important financial KPIs Organic volume growth Higher than market growth Operating profit Double-digit
More informationInterim report January - March 2015
Interim report January - March 2015 May 6, 2015 Stable earnings geared for growth Introduction to Hoist Finance Introduction Established in 1994, Hoist Finance is a leading debt restructuring partner to
More informationFredrik Nilsson, Chief Financial Officer. CFO update. The Co-Development Company
Fredrik Nilsson, Chief Financial Officer CFO update Good progress in most of the focus areas 2018 Organic volume growth Higher than market Organic growth Higher growth than underlying markets Operating
More informationQ4 Report Johan Molin President & CEO
Q4 Report 2013 Johan Molin President & CEO 1 Financial highlights Q4 2013 Strong ending of the year Strong growth in Global Tech and Americas Good growth in APAC and ESD EMEA bottoming Important gains
More informationQ2 Report 2015 Johan Molin President and CEO
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience Q2 Report 2015 Johan Molin President and CEO Financial highlights
More informationMr Green & Co AB. Interim Report January-September Per Norman CEO & Simon Falk CFO. 27 October 2017 Conference Call
Mr Green & Co AB Interim Report January-September 2017 Per Norman CEO & Simon Falk CFO 27 October 2017 Conference Call Revenues +28.4% EBITDA margin 17.1% Customer deposits +24.8% Q317 vs Q316 2 Continued
More informationInterim report January March 2018
Interim report January March 2018 Click Telephone to edit conference Master title style May 3, 2018 Thomas Berglund CEO Olof Bengtsson CFO Solid start considering calendar effects and a temporary severe
More informationCembrit Group Q Unaudited interim report
Cembrit Group Q4 2017 Unaudited interim report 2017 main events COMMENTARY Strong demand across both markets and product categories resulted in revenue growth of 7.9% YoY 2017 EBITDA showed solid underlying
More informationMr Green & Co AB. Interim Report January - September Per Norman CEO & Simon Falk CFO. October 28, 2016
Mr Green & Co AB Interim Report January - September Per Norman CEO & Simon Falk CFO October 28, 1 vs 2 Delivering on our new strategy Mr Green 2.0 FIVE CORNERSTONES; BRAND, USER EXPERIENCE, PRODUCT OFFERING,
More informationFOURTH QUARTER February 2010
FOURTH QUARTER 2009 9 February 2010 AGENDA CEO review Financial review Concluding remarks Harri Koponen Lars Nilsson Harri Koponen 2 2010-02-09 Fourth quarter 2009 HIGHLIGHTS Q4 Solid operational result
More informationPresentation Q3 Interim Report Stockholm, October 23, 2008
Presentation Q3 Interim Report 2008 Stockholm, October 23, 2008 Agenda 1. Business Summary William Cooper (CEO) 2. Financial Summary Casper Seifert (CFO) 3. Summary and Outlook William Cooper (CEO) 4.
More informationYear end report. January-December st of January 2018 Mikael Ericson, President and CEO Erik Forsberg, CFO
Year end report January-December 2017 31 st of January 2018 Mikael Ericson, President and CEO Erik Forsberg, CFO Agenda 1. Highlights for the fourth quarter and FY 2017 2. Key messages from Capital Markets
More informationSIX MONTHS REPORT, JAN JUN 2018
SIX MONTHS REPORT, JAN JUN 2018 TELEPHONE/AUDIO CONFERENCE 11 JULY 2018, AT 11.00 CET TOMMY ANDERSSON, PRESIDENT AND CEO HELENA WENNERSTRÖM, EVP AND CFO DIRECT LINK AUDIOCAST: HTTPS://TV.STREAMFABRIKEN.COM/BULTEN
More informationInterim report July - September 2016
Interim report July - September 2016 October 19 th, 2016 Mikael Ericson, CEO Erik Forsberg, CFO 2 Q3 2016 Highlights Continued good financial development All financial targets met: EPS growth, PD RoI and
More informationInterim report presentation Q October 31, 2017
Interim report presentation 2017 October 31, 2017 Ulf Larsson, CEO Summary 2017 Strong market with increasing prices Sales growth of 12% vs 2016 Volumes +11%, price/mix +3%, currency -2% EBITDA 1) up 25%
More informationWebcast Year end results February 19, 2014
Webcast Year end results 2013 February 19, 2014 1 Disclaimer Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of
More informationUDG Healthcare plc Preliminary Results Presentation FY17. London Stock Exchange, 28 th November 2017
UDG Healthcare plc Preliminary Results Presentation FY17 London Stock Exchange, 28 th November 2017 Forward Looking Statements This Presentation has been prepared by UDG Healthcare plc and contains certain
More informationContent. Key data on Transcom. Performance in Q Q&A
Content Key data on Transcom Performance in Q3 2012 Q&A 2 Key data - Transcom Global specialist of outsourced customer and credit management services Established in 1995 and listed on NASDAQ OMX Stockholm
More information4Q 16 Earnings Call Presentation. August 29, 2016
4Q 16 Earnings Call Presentation August 29, 2016 Agenda John Chiminski, President & Chief Executive Officer 4Q 16 Highlights Matt Walsh, Executive VP & Chief Financial Officer Business Update by Segment
More informationQ3 Report Johan Molin President & CEO
Q3 Report 2014 Johan Molin President & CEO 1 Financial highlights Q3 2014 Continued strong development Strong growth in Americas and ESD Good growth in EMEA and APAC Growth in Global Tech Investments in
More informationH Interim Results. 18 May 2017
H1 2017 Interim Results 18 May 2017 Agenda Highlights - Peter Fankhauser CEO Financial results Strategic progress Current trading and outlook Page 2 Strategic actions leading to improved performance Growing
More informationFinancial update. Mr. Jan Allde CFO Alfa Laval Group.
Financial update Mr. Jan Allde CFO Alfa Laval Group Evolution over almost 20 years Four phases from 2001 43 35 20 30 Phase 3: Aquired growth Order intake: 30-35 BnSEK Adjusted EBITA: 5-6 BnSEK Phase 4:
More information26 FEBRUARY 2019 FULL YEAR RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018 SIGNIFICANT PROGRESS ON STRATEGIC PRIORITIES AND IMPROVED PROFIT MARGIN
26 FEBRUARY 2019 FULL YEAR RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018 SIGNIFICANT PROGRESS ON STRATEGIC PRIORITIES AND IMPROVED PROFIT MARGIN 2018 HIGHLIGHTS Continued progress on operational and strategic
More informationInterim Report January September 2011
Interim Report January September 2011 Stockholm, 20 October 2011 Geoffrey McDonough (CEO) and Lars Sandström (CFO) We provide valuable medicines to patients with rare diseases Disclaimer In order to utilize
More informationFull year report January December 2017
Full year report January December 2017 Telephone conference February 7, 2018 Thomas Berglund, CEO Olof Bengtsson, CFO Solid Q4 now speeding up the journey of specialization and digitalization Highlights
More informationQ2 report. Richard Hausmann. Gustaf Salford. November 30, President and CEO CFO
Q2 report November 30, 2017 Richard Hausmann President and CEO Gustaf Salford CFO Important information This presentation includes forward-looking statements including, but not limited to, statements relating
More informationQ3 Report 2007 Johan Molin, President & CEO
Q3 Report 2007 Johan Molin, President & CEO 1 Financial Highlights Q3 Q3 - Solid improvement Good continued growth in all areas Raw material compensated & efficiency gains Earnings improvements in all
More informationSIX MONTHS REPORT, JAN JUN 2017
SIX MONTHS REPORT, JAN JUN 2017 TELEPHONE/AUDIO CONFERENCE 12 JULY 2017, AT 11.00 CET TOMMY ANDERSSON, PRESIDENT AND CEO HELENA WENNERSTRÖM, EVP AND CFO DIRECT LINK AUDIOCAST: HTTPS://TV.STREAMFABRIKEN.COM/BULTEN
More informationWelcome to the presentation of 1HY 2015 results Global precision engineering champion with Swiss heritage
Welcome to the presentation of 1HY 2015 results Global precision engineering champion with Swiss heritage Focused in technology diversified in end markets SFS representatives Heinrich Spoerry Chairman
More informationQ Interim Report
Q1 2013 Interim Report David Woolley (CEO) & David Bessant (CFO) 1 Agenda Q1 2013 Highlights DW Summary of financial results DB Q2 2013 Outlook DW Q&A DW & DB 2 Q1 2013 Highlights Activity in Q1 2013 showed
More information25 October Q Revenues. Gilles Petit, CEO Arnaud Louet, CFO
Q3 2016 Revenues Gilles Petit, CEO Arnaud Louet, CFO Q3 2016 Revenues FORWARD LOOKING STATEMENTS This presentation contains certain statements that constitute "forward-looking statements", including but
More informationInterim report January - June 2015
Interim report January - June 2015 July 31, 2015 Continued stable earnings and growth Introduction to Hoist Finance Introduction Established in 1994, Hoist Finance is a leading debt restructuring partner
More informationTHIRD QUARTER October 2009
THIRD QUARTER 2009 21 October 2009 AGENDA CEO review Financial review Concluding remarks Harri Koponen Lars Nilsson Harri Koponen 2 2009-10-21 Third quarter 2009 HIGHLIGHTS Q3 Solid result with all regions
More informationNilfisk Financial Results 2017 Webcast presentation - February 28
Webcast presentation - February 28 Today s presenters Nilfisk CEO Hans Henrik Lund Nilfisk CFO Karina Deacon Page 2 Agenda 1 2 3 4 5 6 Highlights Business unit update Financials Nilfisk Next Outlook 2018
More informationINTERIM REPORT JANUARY 29 FOURTH QUARTER 2014
INTERIM REPORT JANUARY 29 FOURTH QUARTER 2014 FULL YEAR 2014 ACTIVE PORTFOLIO MANAGEMENT Acquisition of Varel International Energy Services Divestments of Sandvik Material Technologies distribution business
More informationAEGIS GROUP PLC 2008 ANNUAL RESULTS. 19 March 2009
AEGIS GROUP PLC 2008 ANNUAL RESULTS 19 March 2009 AGENDA OVERVIEW OF RESULTS John Napier FINANCIAL REVIEW Alicja Lesniak OUTLOOK John Napier Q&A Aegis Group plc Page 2 OVERVIEW OF RESULTS John Napier,
More informationQ3 Report October 25, 2017
Q3 Report 2017 October 25, 2017 CEO s comments A weak operating profit, 49 MSEK (91). Different trends across the business. Organic sales growth: APAC +9% EMEA -5% Americas +/- 0 Overall the sales contracted
More informationYear End Report 2006 Johan Molin President & CEO
Year End Report 2006 Johan Molin President & CEO Financial Highlights Q4 Q4 Continued with high growth rates Record profitability in Global Technology and Entrance Systems Continued recovery in Asia Pacific
More informationQ3 report 2018 Press and analyst presentation. 25 October, 2018 Per Strömberg, CEO Sven Lindskog, CFO
Q3 report 2018 Press and analyst presentation 25 October, 2018 Per Strömberg, CEO Sven Lindskog, CFO In brief Improved EBIT Logistic costs weighing down profits High activity level continues 2 Improved
More informationNobina AB Group. Investor Presentation Q4 and Full Year March 2012 February 2013
Nobina AB Group Investor Presentation Q4 and Full Year March 2012 February 2013 This presentation includes statements regarding current expectations going forward, but subject to risks and uncertainties.
More informationQ3 report November Per Strömberg, CEO Sven Lindskog, CFO
report 11 November Per Strömberg, CEO Sven Lindskog, CFO Good quarter across the Group Stable financial development Improved net sales +5% on a comparable basis Improved EBIT MSEK 149 of which Apotek Hjärtat
More informationNordic and France continue the good performance. Enhanced focus on digitalization and specialization.
Capio AB (publ) Interim report Jan Jun 2018 April June 2018 Net sales MSEK 4,179 (3,881). Organic sales growth 1.6% (0.5) and total sales growth 7.7% (8.6) EBITDA 1 MSEK 262 (256) and margin 6.3% (6.6).
More informationQ1/16 Conference Call May 10th, 2016
K+S Aktiengesellschaft Q1/16 Conference Call May 10th, 2016 Dr. Burkhard Lohr, CFO K+S Group Highlights Salt business contributing strongly to group earnings despite mild winter Impact of limited deep-well
More informationBRINGING BUILDINGS TO LIFE
2018 Q3 Mattias Johansson, CEO Nils-Johan Andersson, CFO 6 November 2018 BRINGING BUILDINGS TO LIFE Today s presenters Mattias Johansson, CEO and Group President Nils-Johan Andersson, CFO CEO since 1 January
More informationFY 2016 Conference Call Note
CREATING TOMORROW`S SOLUTIONS Dr. Rudolf Staudigl (CEO), Dr. Tobias Ohler (CFO), March 14th, 2017 0 of 24 Disclaimer The information contained in this presentation is for background purposes only and is
More informationNKT I IR presentation I Interim Report Q November 2014 I 1 NKT. Interim Report Q Webcast, 13 November 2014 at 10:00 CET
13 November 2014 I 1 NKT Interim Report Q3 2014 Webcast, 13 November 2014 at 10:00 CET 13 November 2014 I 2 Forward looking statements This presentation and related comments contain forward-looking statements.
More information3Q 2018 OTELLO CORPORATION ASA
3Q 2018 OTELLO CORPORATION ASA Agenda Executive Summary & Operational Review (CEO, Lars Boilesen) Bemobi (CEO Bemobi, Pedro Ripper) Financial Review (CFO, Petter Lade) 2 Executive Summary 3 Quarterly highlights
More informationASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience.
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience Q3 Report 20 Q3 20 in brief Organic growth in all divisions Strong
More informationNobina AB Group. Investor Presentation Q1 March May 2012
Nobina AB Group Investor Presentation Q1 March May 2012 This presentation includes statements regarding current expectations going forward, but subject to risks and uncertainties. Examples of risks and
More informationQ1 Report 2015 Johan Molin President and CEO
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience Q1 Report 2015 Johan Molin President and CEO Financial highlights
More informationInterim report 3,
Richard Laube, CEO Oliver Walker, CFO Zurich 8 November 2012 Disclaimer This presentation contains forward-looking statements based on beliefs of Nobel Biocare's management. When used in this presentation,
More informationFourth Quarter and Full Year February 8, 2018
Fourth Quarter and Full Year 2017 February 8, 2018 1 Welcome to our presentation of Tobii s year-end report Henrik Eskilsson, CEO Johan Wilsby, CFO 2 Fourth quarter in summary Very strong sales growth
More informationSECOND QUARTER July 2009
SECOND QUARTER 29 22 July 29 AGENDA CEO review Financial review Concluding remarks Harri Koponen Lars Nilsson Harri Koponen 2 29-7-22 Second quarter 29 HIGHLIGHTS Q2 Record result with all regions performing
More informationEVRY ASA Q PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER
1 EVRY ASA Q1 2018 PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER Agenda Group highlights Business update Financial highlights Business area performance Targets and Concluding remarks Q&A 2 Group highlights
More informationVOLVO CAR GROUP results presentation January December 2016
VOLVO CAR GROUP results presentation January December Håkan Samuelsson, president & CEO Hans oscarsson, senior vice president & CFO DISCLAIMER By accepting this document, the person to whom it is provided
More informationQ4&FY 2018 Investor Presentation
Q4&FY 2018 Investor Presentation Jon Sigurdsson, President & CEO Sveinn Solvason, CFO 5 February 2019 1. FY 2018 highlights 2. Q4 2018 review 3. Guidance for 2019 4. Summary 1 FY 2018 vs. guidance Guidance
More informationQ Interim Management Statement
Q1 2014 Interim Management Statement Key messages and agenda for today 1 Delivering sustainable profitable growth 2 Delivering further financial improvement 3 Delivering a step change in profitable growth
More informationMerck FY/Q Financial Summary for Investors and Analysts
Merck FY/Q4 2017 Financial Summary for Investors and Analysts Performance amid headwinds: Healthcare sound core business; successful launches of Mavenclad & Bavencio Life Science strong performance above
More informationNobina AB Group. Investor presentation Q2 Jun Aug 2010/2011
Nobina AB Group Investor presentation Q2 Jun Aug 2010/2011 This presentation includes statements regarding current expectations going forward, but subject to risks and uncertainties. Examples of risks
More informationNobina AB Group. Investor Presentation Q3 March November 2013
Nobina AB Group Investor Presentation Q3 March November 2013 This presentation includes statements regarding the current expectations of the company s future development, and such estimations are, by their
More informationBRINGING BUILDINGS TO LIFE
2017 Q4 Mattias Johansson, CEO Nils-Johan Andersson, CFO 16 February 2018 BRINGING BUILDINGS TO LIFE Today s presenters Mattias Johansson, CEO and Group President Nils-Johan Andersson, CFO CEO since 1
More informationMerck FY/Q Financial Summary for Investors and Analysts
Merck FY/Q4 2018 Financial Summary for Investors and Analysts A year of investments and delivery on Guidance Healthcare Solid organic growth of 5.2% driven by resilient core business with 3% organic growth
More informationInterim Report Q3/2018 October 26, Magnus Welander, CEO Lennart Mauritzson, CFO
Interim Report Q3/2018 October 26, 2018 Magnus Welander, CEO Lennart Mauritzson, CFO Q3/2018 Solid quarter with significant launches for future growth Net sales of SEK 1,561m (1,385) +12.7% (+3.8% excluding
More information24% INTERIM REPORT 1 JANUARY 31 MARCH 2018
INTERIM REPORT Q1 1 JANUARY 31 MARCH 2018 FIRST QUARTER 2018 Net sales increased by 7 per cent to 834.7 MEUR (779.2). Using fixed exchange rates and a comparable group structure (organic growth), net sales
More informationFull Year 2018 Results Update. 27 November 2018
Full Year 2018 Results Update 27 November 2018 Agenda Summary - Peter Fankhauser CEO Financial results Strategic progress Current trading Page 2 2018: A Summary Group revenue up 6% on a like-for-like basis
More informationSandvik. Tentative market. Interim report on second quarter Sandvik second quarter 2013
Tentative market 1 Quarterly highlights Stable but tentative market Unchanged market conditions for Sandvik Machining Solutions, Sandvik Materials Technology and Sandvik Venture Weaker demand for Sandvik
More informationQuality through specialisation Q3 REPORT. October 25, Daniel Öhman, CEO Philip Delborn, CFO
Quality through specialisation REPORT October 25, 2018 Daniel Öhman, CEO Philip Delborn, CFO 2 Agenda CEO reflections on Financials Quality outcomes 3 12,3% organic growth in the third quarter MSEK Revenues
More information2017 Full Year Results. 22 November 2017
2017 Full Year Results 22 November 2017 Agenda Highlights - Peter Fankhauser CEO Financial results Strategic progress Current trading and outlook Page 2 Strong demand for our holidays driving growth Revenue
More informationINTERIM RESULTS Q2-2012
INTERIM RESULTS Q2-2012 KURT RITTER President and CEO KNUT KLEIVEN Deputy President and CFO Friday, July 13, 2012 Margin expansion driven by a solid RevPAR growth 6% L/L RevPAR growth L/L RevPAR grew 6%,
More informationBAML Conference - Miami
BAML Conference - Miami Francois Luscan, President & CEO Xavier Leclerc de Hauteclocque, CFO December 3, 2013 Forward Looking Statement This presentation may include forward-looking statements. Forward-looking
More informationASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience.
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience Q4 Report 20 Q4 20 in brief Organic growth in all divisions Strong
More informationH1 FY17 Results Presentation. H1 FY17 RESULTS PRESENTATION 7 June 2017
Results Presentation RESULTS PRESENTATION 7 June 2017 Strong H1 Performance Delivered strong performance in H1 2017-0.2% like-for-like 1 revenue growth in H1 2017 H1 results are not comparable due to calendar
More informationTobii is the global leader in eye tracking
Aug. 5, 215 Henrik Eskilsson, CEO Esben Olesen, CFO 2 Tobii is the global leader in eye tracking World leader in eye tracking Founded in 21 Headquartered in Sweden, with offices in the US, China, Japan,
More informationASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience.
ASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience Q2 Report 2017 ASSA ABLOY overview January June 2017 Financials (SEK
More informationQ3 Report 2006 Johan Molin President & CEO
Q3 Report 2006 Johan Molin President & CEO Financial Highlights Q3 Continued high growth pace High stable demand in Europe and North America Fargo developing very well Sales SEK 7 736 M +10% +8% organic,
More informationQ2 Report Johan Molin President & CEO
Q2 Report 2009 Johan Molin President & CEO 1 Financial Highlights Q2 2009 Strong performance despite recessionary market Construction in recession throughout the world All divisions affected and declining
More informationPERFORMANCE AMID HEADWINDS
Stefan Oschmann, CEO Marcus Kuhnert, CFO PERFORMANCE AMID HEADWINDS March 8, 2018 We have met all financial targets for 2017 15.3 bn 15.7 bn 4,400 m 4,600 m 6.15 6.50 15,327 m 4,414 m 6.16 Totals may not
More informationQ in brief. Strong organic sales development. Electromechanical products up 30% Strong EBIT growth of 12%
Q4 Report 20 Q4 20 in brief Strong organic sales development Very strong growth in Americas and APAC Strong growth in Global Technologies Good growth in EMEA Growth in Entrance Systems Electromechanical
More informationQ4 Re Q4 R port 2011 Johan Molin President & CEO 1
Q4 Report 2011 Johan Molin President & CEO 1 Financial highlights Q4 2011 Strong quarter with record sales and earnings Strong growth in Asia, Africa, Global Tech and Entrance Systems Stable development
More information2014 Results. 18 February 2015 Madrid
2014 Results 18 February 2015 Madrid Disclaimer/Notice to Recipients This presentation contains forward-looking statements and information relating to Abertis Infraestructuras, S.A. ( Abertis ) and its
More information